China Shineway Pharmaceutical Group Limited (2877.HK) HKSE
8.51
-0.09(-1.05%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
8.51
-0.09(-1.05%)
Currency In HKD
Address
No. 168 Shiluan Street
Shijiazhuang, 051430
China
Phone
86 31 1880 30066
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
3220
First IPO Date
December 02, 2004
| Name | Title | Pay | Year Born |
| King Kuen Hung | Director of Investor Relation | 38,222 | 1966 |
| Huimin Li | Executive Director | 2.43M | 1968 |
| Yunxia Xin | Co-Founder & Executive Director | 3.67M | 1963 |
| Zhenjiang Li | Co-Founder & Executive Chairman | 8.87M | 1955 |
| Bun Ching Lee | Financial Controller & Company Secretary | 0 | 1973 |
China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong. The company offers modern Chinese medicines in the form of soft capsules, granules, and injections, as well as TCM Formula Granules in various therapeutic areas, including cardio-cerebrovascular, anti-viral, orthopedics, pediatrics, gynecology, and gastroenterology. It also trades in agricultural products. The company was incorporated in 2004 and is headquartered in Shijiazhuang, the People's Republic of China. China Shineway Pharmaceutical Group Limited is a subsidiary of Forway Investment Limited.